Green Plains's stock price is trading near its lowest point since its inception. Click here to see why GPRE is a Buy.

UNH faces margin pressure from rising medical cost ratios, regulatory limits, DOJ probes, and overvaluation concerns. Click ...

Analysts remain optimistic with four buy ratings and no sell ratings, underpinned by a price target range averaging $18.50, implying an upside of roughly 18.7% from current levels. Analyst optimism ...

One such trend is investment in renewable energy, which is sustaining robust growth despite political headwinds and appears ...